Product NDC: | 0093-2270 |
Proprietary Name: | Amoxicillin and Clavulanate Potassium |
Non Proprietary Name: | Amoxicillin and Clavulanate Potassium |
Active Ingredient(s): | 200; 28.5 mg/1; mg/1 & nbsp; Amoxicillin and Clavulanate Potassium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, CHEWABLE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-2270 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065205 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050322 |
Package NDC: | 0093-2270-34 |
Package Description: | 20 TABLET, CHEWABLE in 1 BOTTLE (0093-2270-34) |
NDC Code | 0093-2270-34 |
Proprietary Name | Amoxicillin and Clavulanate Potassium |
Package Description | 20 TABLET, CHEWABLE in 1 BOTTLE (0093-2270-34) |
Product NDC | 0093-2270 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Amoxicillin and Clavulanate Potassium |
Dosage Form Name | TABLET, CHEWABLE |
Route Name | ORAL |
Start Marketing Date | 20050322 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | AMOXICILLIN; CLAVULANATE POTASSIUM |
Strength Number | 200; 28.5 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |